Ohio Medical Marijuana Control Program Releases Testing Laboratory Provisional License Application Materials

OHIO:The Ohio Medical Marijuana Control Program (MMCP) is scheduled to accept new testing laboratory license applications beginning the week of August 3, 2020. On its testing laboratories webpage, the MMCP has posted two documents for potential applicants to assist in understanding the key substantive attributes of the application.

Potential applicants may submit questions regarding the application materials using instructions listed on the testing laboratories webpage. All questions must be submitted by July 31, 2020. The MMCP will then provide the frequently asked questions and MMCP answers to potential applicants.

For more information, visit the MMCP’s testing laboratories webpage.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For June 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for June 2020. These numbers include:

  • 147,245 Recommendations
  • 116,497 Registered patients
    • 8,349 Patients with Veteran Status
    • 8,713 Patients with Indigent Status
    • 644 Patients with a Terminal Diagnosis
  • 91,330 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 13,140 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Is Cannabis A Cure For Coronavirus?

MJNews Network Exclusive Report

By Lorelei Caudill

Are we potentially growing our own cure for this global pandemic?

Is the United States the most well-equipped country to potentially conduct one of the most extensive case studies in our world’s history?

Let’s take a more in-depth look at why the answer may be a yes.

In these times of uncertainty, globally, we are starting to look at science and data to help guide critical decisions to determine our new social norm needs. Cannabis is under the microscope on a global level since the beginning of this pandemic.

We are leaning on technology, data, and statistics on how and when to reopen our states and communities. We look to science to help us learn more about how the virus is spread. Some of the world’s best doctors have now taught us “How to wash our hands.” It seems a little crazy, right?

When we think of COVID19 and Cannabis, we need to do the same and lean scientific data from successful cannabis studies in the past (which is quite a bit, despite what many think) and watch the continuing studies with COVID19 scientists are conducting today on a global level.

Initially, some may say, “Nope, I consume cannabis, and I tested positive” (to be honest in my current COVID Survey has only been one person since I published on March 21st).

See the source image

Disregarding Cannabis as a potential to help with this global pandemic, is like saying you wash your hands, and you still contracted COVID19.

Realistically everyone’s next questions would be based on scientific data:

  1. What did you wash your hands with?
  2. How long did you wash your hands?
  3. How often did you wash your hands?

We need to think the same way and apply theory and scientific data to Cannabis:

  1. What cannabis product did you consume?
  2. How frequently did you consume Cannabis?
  3. What form factor of Cannabis do you consume? (inhaled, edibles, tinctures, etc.)

Cannabis plants are not all created equally. The plant contains more than 110 possible cannabinoids and over 120 terpenes, all of which work differently in the human body. To add yet another layer of complexity, research has found certain cannabinoids work differently with other cannabinoids/terpenes. This variable is called the entourage effect.

According to Strain Genie :

In addition to how Cannabis interacts with our human endocannabinoid system, there are other scientific data points to consider, our individual DNA. Research Scientist Nicco Reggente Ph.D., co-founder of Strain Genie, takes cannabis science to a whole new level by providing insight and data required to understand how we can use human DNA to further analyze how an individual metabolizes Cannabis, including the infamous intoxicating compound THC.

Strain Genie analyzes over 450 genetic biomarkers to recommend the best consumption methods and ratios per consumer. With this type of data and information, we can be less fearful of Cannabis as a potential aid in COVID19, knowing we will not have to walk around high or heavily sedated to prevent contraction and spread. It may even help you wash your hands a little longer!

Strain Genie uses DNA biomarkers to align cannabinoids and terpenes within the cannabis plant the help tame or mitigate much of the “high” with Cannabis by providing a custom THC: CBD ratio along with additional terpenes to pair when looking to combat things like cannabis-induced anxiety in individuals that may also be genetically predisposed to having depression, PTSD, or OCD.

Let’s Put Actual COVID19 Under A Microscope With Cannabis:

Next, let’s apply this potential:

As you can see, the public-facing laboratory test for each harvest in our legal markets holds valuable data.  This is the type of data we can use to help propel us forward when thinking about Cannabis and the potential with COVID19. Cannabis consumers may request their products laboratory test upon purchase.

Could this lead to one of the most extensive human case studies in cannabis history?

Slight curveball, not every state-level legal growing operation, is required to provide a terpene content and potency profile. Currently, California, Michigan, Connecticut, and our nation’s capital District of Columbia are the only places that require a terpene profile on top of the cannabinoid profile per harvest; this makes them prime candidates to further research!

In closing, I believe we are much closer than ever to have the ability to quickly link cannabis COVID19 when looking for ways to prevent the spread, and potential treatments. We may find Cannabis as a temporary relief until a vaccine is created. This would allow us to open up more safely and to mitigate much of the risk. The world’s scientists, cultivators, and our states rigorous regulations and testing requirements that have progressed us forward while leaving a valuable data trail in a moment when time is not the most kind.

Caveats – AS ALWAYS PLEASE CONSULT WITH YOUR PRIMARY CARE PHYSICIAN BEFORE PURCHASING OR CONSUMING CANNABIS BASED PRODUCTS

  • Smoking cannabis is unfavorable, regardless.
  • Consuming cannabis may pose a risk to pregnant women.
  • Products with THC are not recommended for consumers with some cancer types where tumors are present.
  • Be aware Cannabis is known to have interactions with other medications.

About Lorelei Caudill – Cannabis Science 101 – www.cannabisque.org

I am a mother, a sister, a daughter, and a granddaughter. My family and I have personal experience with the medicinal value of Cannabis.

Over the past few years, I have dedicated much of my spare time to understand the science behind the “how” and “why” Cannabis works with the human body. Why do some consumers benefit from the medicinal value of Cannabis while others do not? Why would one product have little to no results, while others not only relieve symptoms but help with the root condition?

My goal with Cannabisque is to provide an unbiased platform of educational content created directly from highly regulated studies to educate Cannabis curious consumers globally as we learn more about this miracle plant the promise scientists are documenting in research today.

Pritzker Administration Announces Fourth Month Sales Totals For Illinois Adult Use Cannabis

State’s new adult-use cannabis industry generated more than $37 million in sales in April

ILLINOIS: The Illinois Department of Financial and Professional Regulation has announced preliminary numbers show statewide adult-use cannabis sales in April totaled $37,260,497.89. Dispensaries across the state sold 818,954 items over the 30-day period. Sales to Illinois residents totaled $29,735,650.41, while sales to out-of-state residents totaled $7,524,847.47. These figures do not include taxes collected. A portion of every cannabis sale will be reinvested in communities harmed most by the failed war on drugs.

Medical and adult use cannabis dispensaries remain open as part of the essential businesses and operations named in Governor Pritzker’s executive order signed on March 20, 2020. Both sides of the cannabis industry were included to ensure the cannabis supplier industry protects medical cannabis patients during the COVID-19 pandemic. Additionally, the revenue generated by adultuse cannabis sales funds the important social justice and equity goals at the core of Illinois’ adult-use law.

“Our top priority is to ensure consumers are safe when they go to a dispensary to purchase cannabis,” said Toi Hutchinson, Senior Advisor for Cannabis Control to Gov. Pritzker. “The steps we’ve taken to increase social distancing at dispensaries are accomplishing that, while also enabling this new industry to continue to grow. As such, curbside pickup will remain an option for medical cannabis users to obtain the product they need through May 30.”

Dispensaries are permitted to sell medical cannabis outside of their limited access area on their property or on a public walkway or curb adjacent to the dispensary. Medical cannabis patients will be able to continue to utilize their designated caregiver to purchase medicine for them. However, dispensaries may not deliver medical cannabis to a patient or caregiver’s home. These rules do not apply to adult-use cannabis sales; those must still take place inside the limited access area. A complete list of the rules extended may be found here.

Ohio Board Of Pharmacy Releases MMJ Patient & Caregiver Numbers For March 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for March 2020. These numbers include:

  • 113,359 Recommendations
  • 94,356 Registered patients
    • 7,031 Patients with Veteran Status
    • 6,990 Patients with Indigent Status
    • 544 Patients with a Terminal Diagnosis
  • 69,585 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 10,790 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

CANADA: Cannalogue Introduces COVID-19 Compassionate Care Program For Medical Cannabis

Physician-led online marketplace offers discount of 20-50% on select products for frontline workers, seniors and financially strained

CANADA: In response to the closure of storefront retailers due to COVID-19, online marketplace Cannalogue announced today a new Compassionate Care Program that seeks to provide better access to medical cannabis for all Canadians. 

Qualified candidates including first responders, seniors, nurses, teachers, and those facing financial strain due to work shortage/layoffs can enroll in the program to receive selected products at a discount of 20-50%.  The doctor-recommended, Health Canada approved products include oils, capsules, and dried flowers from as low as $3.50/gram.  As the most inclusive program in Canada, Cannalogue’s Compassionate Care Program is also available to veterans, individuals currently enrolled in a disability, federal or provincial assistance program and Indigenous peoples.

“COVID-19 has had a devastating effect on all Canadians” says President and CEO, Dr. Mohan Cooray. “As a result, we’ve seen an upsurge in cannabis use among patients managing symptoms such as pain, anxiety, difficulty sleeping, and stress – especially from symptoms related to COVID-19 isolation.  Cannabis is a natural plant medicine that can be used safely to manage mental health issues without the dependency effects we see from alcohol, opioids or narcotics.  During this unprecedented time and without access to storefront retailers, we want to help Canadians receive the products they need,” he says.

Additionally, with limited access to doctors or pharmacists during self-isolation, Cannalogue’s medical staff can assess and provide dosage recommendations over the phone.  “Cannalogue is an essential national medical service that Health Canada has confirmed will be fully available to patients during the pandemic. No matter how long we face the challenges of COVID-19, Cannalogue will be here to help,” says Dr. Cooray.

Ohio Board Of Pharmacy Publishes Updated MMJ Patient & Caregiver Numbers For February 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for February 2020. These numbers include:

  • 102,200 Recommendations
  • 88,306 Registered patients
    • 6,545 Patients with Veteran Status
    • 6,018 Patients with Indigent Status
    • 506 Patients with a Terminal Diagnosis
  • 64,932 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 9,793 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Tilray Releases 11 Million Shares From Lock-Up Agreement

CANADA: Tilray, a global pioneer in cannabis production, research, cultivation and distribution, announced that the Board of Directors of Tilray unanimously approved the pro rata release of 11 million shares of Class 2 common stock held by the former equity holders of Privateer Holdings, Inc.

The shares are being released from lock-up agreements entered into in under the Agreement and Plan of Merger and Reorganization, dated September 9, 2019, by and among Tilray, Privateer, Down River Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Tilray, and Michael Blue, as the Stockholder Representative. The waiver and release will take effect on April 3, 2020, and the released shares may be sold on or after that date, subject to applicable securities law or contractual limitations.

A previously announced agreement between Tilray and Privateer required that each Privateer equity holder who received the shares of Tilray stock or options to purchase Tilray stock in the merger were subject to a lock-up allowing for the sale of such shares only under certain circumstances over a two-year period beginning December 12, 2020. During the first year following the closing of the merger, shares will be released only pursuant to certain offerings or sales arranged by and at the discretion of Tilray. The pro rata release will be treated as a “permitted sale” under the lock-up agreements, waiving the release requirements with respect to such shares included in the lock-up agreement.

“The shares to be released on April 3, 2020 are part of the previously announced release of Tilray stock over a two-year period,” said Michael Kruteck, Tilray’s Chief Financial Officer. “We believe the staggered release of locked-up shares, as well as strategic and marketed offerings, will manage our public float in an orderly fashion.”

The waiver and release announced today will apply on a pro rata basis to each former Privateer equity holder who received shares of or options to purchase Tilray Class 2 common stock in the merger, including certain Tilray officers and directors.

The waiver and release of the 11 million shares represents approximately 14.5% of the locked-up shares (including for purposes of this percentage calculation shares that remain subject to escrow and/or subject to outstanding assumed stock options).

Ohio Board Of Pharmacy Awards Third Dispensary Certificate Of Operation In Newark

State_of_Ohio_Board_of_pharmacy_logo2C

 

OHIO: The State of Ohio Board of Pharmacy today awarded a Dispensary Certificate of Operation to Herbology, located at 1150 N. 21st St., Newark.

The Board has now issued 50 Dispensary Certificates of Operation.

The interactive map of Dispensaries with Certificates of Operation will be updated within two business days.

Ohio Board Of Pharmacy Awards Second Dispensary Certificate Of Operation In Newark

State_of_Ohio_Board_of_pharmacy_logo2C

OHIO: The State of Ohio Board of Pharmacy today awarded a Dispensary Certificate of Operation to Ohio Grown Therapies, located at 1246 N. 21st St., Newark.

The Board has now issued 48 Dispensary Certificates of Operation.

The interactive map of Dispensaries with Certificates of Operation will be updated within two business days.